Angeborene Herzfehler im Erwachsenenalter

Zusammenfassung

Angeborene Herzfehler im Erwachsenenalter sind häufig und können inzwischen gut behandelt werden. Interventionelle Techniken zum Verschluss von Vorhofseptumdefekten und die Implantation von Transkatheter-Herzklappen setzen sich als neue Therapieverfahren durch. Chirurgisch werden Rekonstruktionen von Klappenvitien dem Klappenersatz vorgezogen. Die Endokarditisprophylaxe beschränkt sich auf Hoch-Risiko-Konstellationen.

Abstract

Adult congenital heart diseases are common, and nowadays treatable with convincing success. Interventional occlusion of septal defects, and percutaneous valve implantation become widely accepted. Considering trend analysis, surgical repair of malfunctioning valves is favored over valve replacement. Endocarditis prophylaxis is reserved for high risk situations.

Schlüsselwörter

Vorhofseptumdefekt - bikuspide Aortenklappe - Mitralklappenprolaps - Endokarditisprophylaxe

Keywords

atrial septal defect - bicuspid aortic valve - mitral valve prolapse - prevention of infective endocarditis

• Literatur

• 1 Al-Nawas B, Block M, Ertl G et al. Kommentierte Zusammenfassung der Leitlinien der European Society of Cardiology zur Infektiösen Endokarditis (Neuauflage 2009). Kardiologe 2010; 4: 285-294
• 2 Ashikhmina E, Sundt 3rd TM, Dearani JA et al. Repair of the bicuspid aortic valve: a viable alternative to replacement with a bioprosthesis. J Thorac Cardiovasc Surg 2010; 139: 1395-1401
• 3 Baumgartner H, Bonhoeffer P, De Groot NM et al. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J 2010; 31: 2915-2957
• 4 Baumgartner H, Kaemmerer H, Gohlke-Baerwolf C et al. Kommentar zu den neuen Leitlinien (2010) der Europäischen Gesellschaft für Kardiologie (ESC) zum Management von Erwachsenen mit angeborenen Herzfehlern (EMAH). Kardiologe 2011; 5: 157-161
• 5 Bonhoeffer P, Boudjemline Y, Saliba Z et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403-1405
• 6 Carroll JD, Saver JL, Thaler DE et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013; 368: 1092-1100
• 7 Furlan AJ. PFO Closure: CLOSURE. Stroke 2013; 44: S45-47
• 8 Habib G, Hoen B, Tornos P et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J 2009; 30: 2369-2413
• 9 Kari FA, Siepe M, Sievers HH et al. Repair of the regurgitant bicuspid or tricuspid aortic valve: background, principles, and outcomes. Circulation 2013; 128: 854-863
• 10 MacHaalany J, Senechal M, OʼConnor K et al. Early and late mortality after repair or replacement in mitral valve prolapse and functional ischemic mitral regurgitation: a systematic review and meta-analysis of observational studies. Int J Cardiol 2014; 173: 499-505
• 11 Marelli AJ, Ionescu-Ittu R, Mackie AS et al. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 2014; 130: 749-756
• 12 Meier B, Kalesan B, Mattle HP et al. Percutaneous closure of patent foramen ovale in cryptogenic embolism. N Engl J Med 2013; 368: 1083-1091
• 13 Mohty D, Orszulak TA, Schaff HV et al. Very long-term survival and durability of mitral valve repair for mitral valve prolapse. Circulation 2001; 104: I1-I7
• 14 Vahanian A, Alfieri O, Andreotti F et al. Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33: 2451-2496
• 15 Verheugt CL, Uiterwaal CS, van der Velde ET et al. Turning 18 with congenital heart disease: prediction of infective endocarditis based on a large population. Eur Heart J 2011; 32: 1926-1934